glp-1 for addiction drugs linked to lower rates in large study of veterans | Science Five things to know about

In the comparison of GLP-1 use vs non-use, 1,610 BC patients with obesity were included

These benefits, along with already widespread use and generally good tolerability profile, have piqued interest in the potential benefit of SGLT2i and GLP1-RA in patients with rheumatologic conditions, who are at higher risk of cardiovascular and renal complications

Apparently, anybody

223 , e13038 (2018)

When to Contact Your Healthcare Provider While mild to moderate fatigue is common, it should not be debilitating

In addition to blunted monoaminergic neurotransmission, it was also shown that deficiency in neurotrophic factor effects, disturbances in neurogenesis and synaptogenesis, chronic neuroinflammatory processes, and dysregulation of the hypothalamicpituitaryadrenal (HPA) axis can largely contribute to the manifestation of depressive symptoms in patients [3,4,5]